Latent infection with Epstein-Barr virus in odontogenic disorders: Comparison among ameloblastoma, dentigerous cyst and odontogenic keratocyst

Pathology International

Volumn 47, Issue 7, 1997, Pages 449-453

  Fujita, Shuichi ^a   Shibata, Yasuaki ^a   Takahashi, Hiroshi ^a   Tsuda, Nobuo ^b   Okabe, Haruo ^a  

^a NAGASAKI UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Ameloblastoma; Epstein Barr virus; Odontogenic cyst

Indexed keywords

ADOLESCENT; ADULT; AGED; AMELOBLASTOMA; ARTICLE; CHILD; CONTROLLED STUDY; EPSTEIN BARR VIRUS; FEMALE; HISTOGENESIS; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; ODONTOGENIC CYST; PRIORITY JOURNAL; TERATOMA; VIRUS CELL TRANSFORMATION; VIRUS DETECTION; VIRUS INFECTION;

EID: 0030915023     PISSN: 13205463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1827.1997.tb04523.x     Document Type: Article

References (25)

1. Dalgleish AG. Viruses and cancer. Br. Med. Bull. 1991; 47: 21-46.
2. Hildesheim A, Levine PH. Etiology of nasopharyngeal carcinoma: A review. Epidemiol. Rev. 1993; 15: 466-485.
3. Wu T-C, Mann RB, Epstein JI et al. Abundant expression of EBER1 small nuclear RNA in nasopharyngeal carcinoma: A morphologically distinctive target for detection of Epstein-Barr virus in formalin-fixed paraffin-embedded carcinoma specimens. Am. J. Pathol. 1991; 138: 1461-1469.
4. Herbst H, Niedobitek G, Kneba M et al. High incidence of Epstein-Barr virus genomes in Hodgkin's disease. Am. J. Pathol. 1990; 137: 13-18.
5. Hummel WI, Anagnostopoulos I, Korbjuhn P, Stein H. Epstein-Barr virus in B-cell non-Hodgkin's lymphomas: Unexpected infection patterns and different infection incidence in low- and high-grade types. J. Pathol. 1995; 175: 263-271.
6. Rochford R, Mosier DE. Immunobiology of Epstein-Barr virus-associated lymphomas. Clin. Immunol. Immunopathol. 1994; 71: 256-259.
7. Gulley ML, Pulitzer DR, Eagan PA, Schneider BG. Epstein-Barr virus infection is an early event in gastric carcinogenesis and is independent of bcl-2 expression and p53 accumulation. Hum. Pathol. 1996; 27: 20-27.
8. Iezzoni JC, Gaffey MJ, Weiss LM. The role of Epstein-Barr virus in lymphoepithelioma-like carcinomas. Am. J. Clin. Pathol. 1995; 103: 308-315.
9. Kasai K, Sato Y, Kameya T et al. Incidence of latent infection of Epstein-Barr virus in lung cancers: An analysis of EBER1 expression in lung cancers by in situ hybridization. J. Pathol. 1994; 174: 257-265.
10. Chan JKC, Yip TTC, Tsang WYW, Poon YF, Wong CSC, Ma VWS. Specific association of Epstein-Barr virus with lymphoepithelial carcinoma among tumors and tumor like lesions of the salivary gland. Arch. Pathol. Lab. Med. 1994; 118: 994-997.
11. Knecht H, Brousset P, Bachmann E, Sandvej K, Odermatt BF. Latent membrane protein 1: A key oncogene in EBV-related carcinogenesis? Acta Haematol. 1993; 90: 167-171.
12. Henderson S, Rowe M, Gregory C et al. Induction of bcl-2 expression by Epstein-Barr virus latent membrane protein 1 protects infected B cells from programmed cell death. Cell 1991; 65: 1107-1115.
13. Wang D, Liebowitz D, Wang F et al. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: Deletion of the amino terminus abolishes activity. J. Virol. 1988; 62: 4173-4184.
14. Nishikawa S, Sasaki F. DNA localization in nuclear fragments of apoptotic ameloblasts using anti-DNA immunoelectron microscopy: Programmed cell death of ameloblasts. Histochem. Cell Biol. 1995; 104: 151-159.
15. Shibata S, Suzuki T, Tengan T, Yamashita Y. A histochemical study of apoptosis in the reduced ameloblasts of erupting mouse molars. Arch. Oral Biol. 1995; 40: 677-680.
16. Kramer IRH, Pindborg JJ, Shear M, eds. Histological Typing of Odontogenic Tumours, 2nd edn. Springer-Verlag, Berlin, 1992.
17. Henle W, Henle G. Seroepidemiology of the virus. In: Epstein MA, Achong BG, eds. The Epstein-Barr Virus. Springer-Verlag, Berlin, 1979; 61-78.
18. Akao I, Sato Y, Mukai K et al. Detection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization. Laryngoscope 1991; 101: 279-283.
19. Talacko AA, Teo CG, Griffin BE, Johnson NW. Epstein-Barr virus receptors but not viral DNA are present in normal and malignant oral epithelium. J. Oral Pathol. Med. 1991; 20: 20-25.
20. Horiuchi K, Mishima K, Ichijima K, Sugimura M, Ishida T, Kirita T. Epstein-Barr virus in the proliferative disease of squamous epithelium in the oral cavity. Oral Surg. Oral Med. Oral Pathol. 1995; 79: 57-63.
21. Murray PG, Niedobitek G, Kremmer E et al. In situ detection of the Epstein-Barr virus-encoded nuclear antigen 1 in oral hairy leukoplakia and virus-associated carcinomas. J. Pathol. 1996; 178: 44-47.
22. Fawcett DW. The teeth. In: Fawcett DW, Raviola E, eds. Bloom and Fawcett. A Textbook of Histology, 12th edn. Chapman & Hall, New York, 1994; 578-592.
23. Tokunaga M, Uemura Y, Tokudome T et al. Epstein-Barr virus related gastric cancer in Japan: A molecular pathoepidemiological study. Acta Pathol. Jpn. 1993; 43: 574-581.
24. Korbjuhn P, Anagnostopoulos I, Hummel M et al. Frequent latent Epstein-Barr virus infection of neoplastic T cells and bystander B cells in human immunodeficiency virus-negative European peripheral pleomorphic T-cell lymphomas. Blood 1993; 82: 217-223.
25. Anagnostopoulos I, Hummel M. Epstein-Barr virus in tumours. Histopathology 1996; 29: 297-315.